___

• 1. Maldonado YA. Rubeola virus (measles and subacute sclerosing panencephalitis). In: Long SS, Pickering LK, Prober LG (eds), Principles and Practice of Pediatric Infecrious Diseases. 2nd. edition. Churchill Livinstone Inc. 2003pp; 1148-1155. 2. Smyth A. Pneumonia due to viral and atypical organisms and their sequelae. Br Med Bull 2002; 61:247-262. 3. Chalmers I. Why we need to know whether prophylactic antibiotics can reduce measles-related morbidity. Pediatrics 2002; 2: 312-315. 4. Hartter HK, Oyedele OI, Dietz K, et al. Placental transfer and decay maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 2000; 19:635-641. 5. Ibrahim SA, Mustafa OM, Mukhtar MM, et al. Measles in suburban Khartoum: an epidemiological and clinical study. Trop Med Int Health 2002; 5:442-449. 6. Marufu T, Siziya S, Tshimanga M, et al. Factors associated with measles complication in Gweru, Zimbabwe. East Afr Med J 2001; 3:135-138. 7. Quiambao BP, Gatchalian SR, Halonen P, et al. Coinfection is common in measles-associated pneumonia. Pediatr Infect Dis J 1998; 17:89-93. 8. Kaplan LJ, Daum RS, Smaron M, et al. Severe measles in immunucompromised patients. J Am Med Assoc 1992; 267:1237-1241. 9. Acute respiratory infections in children: case management in small hospitals in developing countries. Programme for the control of ARI. Geneva: World Health Organization, 1988. 10. Gunaratne PS, Ranjendran T, Tilakaratne S. Neorological complications of measles. Ceylon Med J 2000; 2:48-50. 11. El-Far F, Sztajnbok J, Marotto PC, et al. Meningoencephalitis in the acute phase of measles. Report of 6 cases. Arq Neuropsiquiatr 2000; 58:136-140. 12. Kaninda AV, Legros D, Jatau M, et al. Measles vaccine effectivenes in standart and early immunization strategies, Niger, 1995. Pediatr Infect Dis J 1998; 17:1034-1039. 13. Caceres VM, Strebel PM. Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infec Dis 2000; 31:110-119. 14. Gans H, Yasukawa L, Rinki M, et al. Immune responses to measles and mumps vaccination of infants at 6,9, and 12 months. J Infect Dis 2001; 184:817-826. 15. Kanra G, Ceyhan M: Elimination of maternal antibodies against measles. Turk J Pediatr 1991; 33:217-220. 16. Epidemiyoji Ünitesi, Viroloji Laboratuvar Şefliği. Yapılan saha çalışmalarındaki kızamık antikor dağılımları. AER 2002; 1:11. 17. Akramuzzaman SM, Cutts FT, Hossain MJ, et al. Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh. Bull WHO 2002; 80:776-782. 18. Mgone JM, Mgone CS, Duke T, et al. Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. P N G Med J 2000; 43:91-97. 19. Thakur JS, Ratho RK, Bhatia SP, et al. Measles outbreak in a Periurban area of Chandigargh: need for improving vaccine coverage and strengtening surveillance. Indian J Pediatr 2002; 69:33-37. 20. Van den Hof S, Conyn-van Spaendonck M, Van Steenbergen JE. Measles epidemic in The Netherlands, 1999–2000. J Infect Dis 2002; 186:1483-1486. 21. Van den Hof S, Smit C, Van Steenbergen JE, et al. Hospitalizations during a measles epidemic in the Netherlands, 1999–2000. Pediatr Infect Dis J 2002; 21:1146-1150. 22. Lertpiriyasuwat C, Kanlayanpotporn J, Deeying J, et al. Measles outbreak in an orphanage, Bangkok, Thailand, September- October 2000. J Med Assoc Thai 2002; 85:653-657. 23. Comittee on Infectious Diseases: Vitamin A treatment of measles. Pediatrics 1993; 91:1014-1015. 24. Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 1994; 170 (Suppl 1):24-31. 25. Atabani SF, Byrnes AA, Jaye A, et al. Natural measles causes prolonged supression of interleukin–12 production. J Infect Dis 2001; 184:1-9. 26. Mustafa MM, Weitman SD, Winick NJ, et al. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993; 16:654-660. 27. Papadopoulu A, Theodoridou M, Syriopoulou V, et al. Hepatitis in children hospitalized with measles: the experience after a Greek epidemic. J Paediatr Child Health 2001; 1:55-57. 28. Okamura A, Itakura O, Yoshiko M, et al. Unusual presentation of measles giant cell pneumonia in a patient with Acquired Immunodeficiency Syndrome. Clin Infect Dis 2001; 32:57-58. 29. Kanra G, Çetin I, Akçören Z, et al. Giant cell pneumonia in a leukemic child in remission: a case report. Turk J Pediatr 2001; 43:338-341..